Mansanades, Juliet J.
HRN: 22-77-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/22/2023
03/29/2023
IVT
600mg
Q8H
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes